CVS Health welcomes Dr. Jeff Balser to its Board of Directors

– USA, RI –  CVS Health (NYSE: CVS) today announced the appointment of Dr. Jeff Balser (M.D., Ph.D.) to its Board of Directors effective immediately.

“On behalf of the Board, I want to welcome Dr. Balser to CVS Health. This is an exciting time for the Company, and we are confident he will be a valuable addition as we continue to redefine health care,” said Board Chair, Roger Farah.

CEO Karen Lynch added, “Dr. Balser’s extensive experience in a wide range of roles across health care organizations will be an invaluable asset for the Board. His deep clinical expertise and leadership of a prestigious health system give him the insight to help support our strategy to serve consumers and meet their health needs differently.”

Dr. Balser also joins the Medical Affairs Committee.

About Dr. Jeffrey R. Balser

Dr. Balser serves as President and CEO of Vanderbilt University Medical Center, its chief executive since 2009, and as Dean of the Vanderbilt University School of Medicine since 2008. VUMC is one of the Southeast’s largest and most prominent academic medical centers, with seven hospitals and 170 outpatient facilities across Tennessee and in neighboring states.

Dr. Balser is a member of the National Academy of Medicine and serves on its governing council. He also currently serves on the boards of VUMC, Tulane University, and the Nashville Health Care Council.

“I believe CVS Health’s vision for primary care and its integrated approach to care delivery will help improve the health experience in our country,” commented Dr. Balser. “I look forward to working with the management team and the Board to help advance the company’s strategy.”

Dr. Balser completed his internship with the Osler Medical Service, residency training in anesthesiology, and fellowship training in both cardiac anesthesiology and critical care medicine at Johns Hopkins in Baltimore, MD. He joined the Hopkins faculty in 1995, practicing cardiac anesthesiology and ICU medicine while leading an NIH-funded research program aimed at the genomic underpinnings of cardiac rhythm disorders. He returned to Vanderbilt in 1998, was appointed chair of the Department of Anesthesiology in 2001, and became VUMC’s chief research officer in 2004. In 2008/09, he was named Dean of the School of Medicine and Vice Chancellor for Health Affairs with executive responsibility for Vanderbilt’s medicine-related educational, research, and clinical service programs, responsibilities that continue since 2016 in his role as President and CEO.

About CVS Health

CVS Health is the leading health solutions company, delivering care as no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels, and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that’s managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs, and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day.

For more information: https://www.cvshealth.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.